GUBRA A/S
1Patents
1Active
1Granted
51Portfolio score
Filing activity: Sep 23, 2021 → Sep 23, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12139520B2 | HAM15-52 analogues with improved amylin receptor (hAMY3R) potency | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.